Outil d'établissement de liens : Possibilités de financements des Fonds pour les essais cliniques
Pour atteindre les buts et les objectifs des trois possibilités de financement du Fonds pour les essais cliniques par un processus accéléré, des rapports étroits doivent être établis. L'outil d'établissement de liens est l'un des moyens utilisés par les IRSC pour favoriser l'établissement de tels liens. Le tableau ci-dessous contient des renseignements sur des personnes et/ou des organismes désirant échanger de l'information ou établir une collaboration en rapport avec une ou plusieurs des trois possibilités de financement lancées par le Fonds pour les essais cliniques.
L'information est donnée sur une base volontaire et ne procure aucun avantage particulier dans l'évaluation ou le financement des demandes. Elles ne remplacent ni ne constituent une inscription ou une lettre d'intention (LOI) à l'une des possibilités de financement connexes.
Avis
L'information est fournie dans la langue dans laquelle le répondant l'a présentée.
| Coordonnées | Lieu | Intervenant/ Type de participant |
Opportunité de financement d'intérêt | Domaine(s) d'intérêt | Autres renseignements |
|---|---|---|---|---|---|
| Michel Chrétien Researcher emeritus michel.chretien@ircm.qc.ca 514-898-4063 Institut de recherches cliniques de Montréal |
Quebec |
Health Professional NGO’s |
Platform: Pan-Canadian Clinical Trials Consortium Projects: Clinical Trials |
Functional endoproteolisis virology immunology |
For more information, please visit Institut de recherches cliniques de Montréal |
| Reda Albadawy Professor Hepatology, Gastroenterology reda.albadawy@fmed.bu.edu.eg 00201091950280 Benha University, Egypt |
British Columbia |
Independent researcher Health Professional International Organization |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Microbiome |
NAFLD, HCC and Fatty Pancreatic Disease |
| Aurelien Balondona aurelien@baune.ca 8259010090 Baüne |
Alberta Ontario Quebec |
Industry |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Remote Patient Monitoring Mental eHealth |
For more information, please visit Baüne. |
|
Aslam Anis National Director, CIHR Canadian HIV Trials Network; Director, Centre for Health Evaluation and Outcome Sciences; Professor and Director pro tem, School of Population and Public Health, UBC aslam.anis@ubc.ca 604-366-8542 CIHR Canadian HIV Trials Network; Centre for Health Evaluation and Outcome Sciences; UBC School of Population and Public Health |
The CTN is a national network with headquarters at the Centre for Health Evaluation and Outcome Sciences in British Columbia and several international sites and network affiliations. | Independent researcher | Platform: Pan-Canadian Clinical Trials Consortium | We are interested in connecting with others to collaborate in forming a Clinical Trials Consortium. |
The CIHR Canadian HIV Trials Network (CTN) offers expertise in communicable diseases and pandemic preparedness. Our team at the Centre for Health Evaluation and Outcome Sciences (CHÉOS) brings further expertise in non-communicable diseases and policy. Additional context: The CTN is a Canada-wide network that has pioneered 30 years of practice-changing clinical studies and trials to prevent, treat and manage HIV, hepatitis C, other sexually transmitted and blood-borne infections and COVID-19. We are a partnership of researchers, people with lived experience and their caregivers, governments, health advocates and the pharmaceutical and biotechnology industry with 70 affiliated sites across Canada and additional international sites and collaborators. CHÉOS is an interdisciplinary collective founded to pursue excellence in health outcomes research. We produce and translate high-quality research evidence to improve health, transform health systems and provide a wide range of support services for health outcomes research and clinical trial studies. |
|
Gail Tomblin Murphy Professor, Vice President Research, Innovation & Discovery gail.tomblinmurphy@nshealth.ca 902-491-5822 Dalhousie University |
Nova Scotia |
Knowledge User Independent researcher Health Professional Provincial/Territorial Government and Agencies |
Platform: Pan-Canadian Clinical Trials Consortium | ||
|
Bijoy Menon Professor bkmmenon@ucalgary.ca 4039448107 University of Calgary |
Alberta |
Knowledge User Independent researcher Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Large clinical trials, pragmatic trials, registry linked and e-data linked trials, systems trials, health technology applications, platform trials, acute stroke, imaging. Artificial Intelligence. | For more information, please visit Google Scholar. |
|
Maggie McIlwaine Network Manager mmcilwaine@cysticfibrosis.ca 6045055715 Cystic Fibrosis Canada |
Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon Network covers all Provinces |
NGO Cystic Fibrosis Clinical Trial Network |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Interested in collaborating with other clinical trial networks to form a Clinical Trials Consortium. Respiratory Diseases | For more information, please visit Cystic Fibrosis Canada. |
|
Whitney Duff Clinical Research Lead ctsu.operations@usask.ca 3069661417 University of Saskatchewan |
Saskatchewan |
Knowledge User Academia |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms |
Research infrastructure and support | For more information, please visit University of Saskatchewan. |
|
Carmela Tartaglia MD carmela.tartaglia@uhn.ca 6479712876 University Health Network |
Ontario | Independent researcher |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Neurodegenerative disease Concussion/mild traumatic brain injury |
|
|
John Boyd Chief Medical Officer john.boyd@hli.ubc.ca 604 682 2344 Black Tusk Research Group |
British Columbia | Industry |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms |
A nimble Site Management Organization with deep expertise in
|
For more information, please visit Black Tusk Research Group. |
|
Susan Fox sfox@uhnresearch.ca 14166699837 University Health Network |
Ontario | Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
||
|
Paaladinesh Thavendiranathan Cardiologist dinesh.thavendiranathan@uhn.ca 4163405326 Peter Munk Cardiac Center, Toronto General Hospital, University Health Network |
Ontario | Independent researcher |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Cardiooncology / cardiotoxicity / cardiovascular imaging | |
|
John Kuruvilla Hematologist / Clinical Investigator john.kuruvilla@uhn.ca 416 946 2821 Princess Margaret Cancer Centre |
Ontario |
Knowledge User Independent researcher Health Professional NGO’s |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Lymphoma Novel therapeutics Stem Cell transplantation Cellular Therapy Translational Research |
|
|
Lillian L Siu Professor lillian.siu@uhn.ca 416-946-2911 Princess Margaret Cancer Centre |
Ontario, Canada | Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Phase I clinical trials, experimental therapeutics, immunotherapy, biomarkers, cancer, oncology | |
|
Atul Humar atul.humar@uhn.ca 4163404241 Toronto General Hospital |
Ontario | Independent researcher | |||
|
Philippe Pibarot Professeur philippe.pibarot@med.ulaval.ca 5142318534 Université Laval |
Quebec | Independent researcher | Platform: Pan-Canadian Clinical Trials Consortium | ||
|
Stephanie Lheureux Associate Professor as of July 1, 2022 Stephanie.Lheureux@uhn.ca 416-946-2818 |
Ontario | Health Professional | Platform: Pan-Canadian Clinical Trials Consortium | ||
|
Jordan Feld Hepatologist, Professor of Medicine jordan.feld@Uhn.ca 416 340 4584 University Health Network, Toronto Centre for Liver Disease |
Ontario |
Independent researcher Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Viral hepatitis - hepatitis B, C, D, E COVID-19 Clinical Trials Virology Innate Immunity Interferon signaling Viral diagnostics Chronic liver disease Wilson Disease |
|
|
Patrick R. Lawler Doctor Patrick.Lawler@uhn.ca 416-340-4800 x7183 University Health Network |
Toronto, Ontario | Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
My research aims to develop personalized medicine approaches for the prevention and treatment of cardiovascular disease and critical illness. This work has a strong scientific focus on inflammation and metabolism, is at the intersection between cardiovascular disease and sepsis, and leverages molecular epidemiology/systems medicine approaches in epidemiology and clinical trials. I also have a focus on Bayesian adaptive/platform trials in critical care medicine, and serve on the International Trial Steering Committee of the REMAPCAP global adaptive platform trial (NCT02735707), on the Protocol Development/Leadership Committee for the NIH/NHLBI ACTIV-4 platform trial (NCT04505774), and as co-Principal Investigator of the ATTACC adaptive trial of anticoagulation in hospitalized patients with COVID-19 (NCT04372589) which completed enrollment of 1,204 patients at 62 hospitals in 4 countries. My research is funded by the Canadian Institutes of Health Research and the U.S. National Institutes of Health, among others. | For more information, please visit University Health Network. |
|
Michael D. Cusimano Neurosurgeon and Professor of Neurosurgery injuryprevention@smh.ca Alternate email: mountain@smh.ca 416 8645312 Unity Health Toronto-St Michael's Hospital, UHN, Sickkids, University of Toronto, Dhalla Lana School of Public Health, Institute of Medical Sciences, Li Ka Shing Knowledge Institute |
Ontario |
Knowledge User Independent researcher Health Professional Also interested in technology development and evaluation |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Neurosurgery-related topics, Public Health, Education, Cognition, brain and pituitary tumours, skull base, traumatic brain injury and concussion, injury prevention and surveillance, policy, NPH, SAH, SDH, critical care issues, life course, trigeminal neuralgia, hemifacial spasm, sleep, geospatial, NPH, AI applications, measurement and evaluation, surgical/medical education, technology development | |
|
Andrew Pinto Doctor andrew.pinto@utoronto.ca 416-864-6060 x76148 University of Toronto |
Ontario | Independent researcher |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Primary care, public health, social determinants of health, pragmatic trials, cluster randomized controlled trials, adaptive platform trials |
I serve as the lead for clinical research at the U of T primary care practice-based research network (UTOPIAN), and co-lead clinical research for an Ontario-wide network (POPLAR). We have developed a primary care clinical trial network, and interested in pragmatic trials of interventions (medications and vaccines, alternative forms of care, changes in payment, social interventions). For more information, please visit Upstream Lab. |
Alison Orth Unit Director, Clinical Trials BC aorth@healthresearchbc.ca (236) 521-2064 Clinical Trials BC, Michael Smith Health Research BC |
British Columbia |
Knowledge User Community Partner NGO’s |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms |
We are interested in connecting with others to collaborate in forming a Clinical Trials Consortium and in partnering/collaborating on a training platform. |
We are part of the Michael Smith Health Research BC organization which comprises the BC SPOR Support Unit, Clinical Trials BC, Research Ethics BC and funding programs that attract, develop and retain BC‘s health research talent. Our purposes are to strengthen BC‘s health research system by supporting the people, institutions and activities that generate and use research based knowledge to promote, restore and maintain the health of British Columbian’s. We support clinical trial investigator sites and institutions to ensure a world class destination for clinical trials focusing on infrastructure and capacity building. With a collaborative approach we enable clinical trial excellence in the Province of the British Columbia. We have a number of provincial level infrastructure and capacity building programs including a province wide Clinical Trial Management System (CTMS), recruitment platform (REACH BC), quality management system and professional development, mentoring and training programs for clinical trial investigators and team members. For more information, please visit Clinical Trials BC. |
|
Nishita Singh Doctor nishitaneurology@gmail.com 4034373524 University of Calgary |
Alberta | Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
stroke, clinical trials | |
|
Paulo Koeberle Associate Professor paulo.koeberle@utoronto.ca 416-786-2894 University of Toronto |
Ontario | Independent researcher |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Glaucoma, vision loss, blindness, retinal ganglion cell degeneration, stroke, central nervous system injury, brain trauma, retinal degeneration | |
|
Ravi Retnakaran Professor Ravi.Retnakaran@SinaiHealth.ca 416-586-4800 ext 3941 Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto; and University of Toronto |
Ontario |
Independent researcher Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
type 2 diabetes; gestational diabetes; preservation of pancreatic beta-cell function | |
|
Rebecca Barnes Executive Director rebecca.barnes@n2canada.ca Network of Networks (N2) |
Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon |
NGO’s |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
The Network of Networks (N2) is a not-for-profit alliance of Canadian clinical research organizations working to enhance clinical research capability and capacity across all therapeutic areas. N2 provides a pan-Canadian and bilingual platform for delivering training and sharing best practices and resources to ensure efficient and high-quality clinical trials. It is helping to increase the impact of clinical trials through its network capacity in Canada. N2 benefits from the collective expertise of 162 member organizations, representing thousands of clinical research professionals. In addition to its highly-engaged membership, N2 has partnerships with the leading organizations for clinical research stakeholders and experts in Canada. |
N2 is Canada’s alliance for excellence in clinical research and the collective national voice for the clinical research community. As it grows and continues to develop new training and resources in direct response to needs voiced by the Canadian clinical research community, it is uniquely positioned to further influence the development of highly qualified personnel (HQP). By building upon the strong foundation N2 has established, including its brand as the national voice, deep and active relationships within the public and private sectors, and broad reach in terms of geography and therapeutic areas, there is an opportunity to drive the activities needed to make Canada a global destination for clinical trials. N2’s envisaged impact areas of particular note include both the earliest part of the clinical research pipeline, by mentoring the next generation of trialists, and the end of the pipeline, by driving more effective knowledge mobilization to help ensure the integration of evidence into decision-making and sharing trial results. For more information, please visit N2 Canada. |
|
William Scott Beattie Professor, Department of Anesthesia and Pain scott.beattie@uhn.ca 16473896927 University of Toronto |
Ontario |
Knowledge User Independent researcher Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium Projects: Clinical Trials |
Perioperative Medicine Pain management |
|
|
Habiballa Inventor New Drug habiba011@gmail.com 249961529854 Private Inventor |
Sudan |
Knowledge User Independent researcher Health Professional Patient Community Partner Industry Provincial/Territorial Government and Agencies NGO’s International Organization |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Experimenting with a new clinically discovered drug from herbs. (active ingredient has been identified) (syrup - injection - tablet) Trade name (Stpone Harbel Medicine). It treats a large number of incurable diseases that are related to immunity. 1/ Rheumatoid arthritis 2 / Rheumatoid 3 / Thyroid gland hyper or underactive 4 / Leukemia 5 / carcinoid tumors 7 / wounds caused by diabetes mellitus 9/ Cold infections, including Covid 19 (helps in recovery and no need for drug serums). 10 / Helps restore the menstrual cycle in some cases in which the menstrual cycle is interrupted 11 / Glaucoma is cured within a week The key (modifies the body's immunity) The key to treatment (complete interpretation.....etc) |
I started to register it with the FDA and I have a serial number. |
|
Sarvesh Logsetty Professor logsetty@umanitoba.ca 204-787-8682 University of Manitoba |
Manitoba Canadian Burn Association, Canadian Frostbite Collaborative |
Knowledge User Independent researcher Health Professional |
Platform: Pan-Canadian Clinical Trials Consortium People: Clinical Trials Fund Training Platforms Projects: Clinical Trials |
Population health, epidemiology, administrative data, clinical trials, injuries, burn injuries, long term outcomes, scar management, Traumatic injury. Long term outcomes |
- Date de modification :